German-Austrian recommendations for the antiretroviral therapy
ثبت نشده
چکیده
With the collaboration of Arastéh K. (Berlin), Arendt G. (Düsseldorf), Bader A. (Bochum), Behrens G. (Hannover), Beichert M. (Mannheim), Berg T. (Potsdam), Bergmann F. (Berlin), Bieniek B. (Berlin), Blauhut B. (Linz), Bogner J. (München), Brockhaus W. (Nürnberg), Brockmeyer N.H. (Bochum), Brodt H.R. (Frankfurt/M), Büscher U. (Berlin), Buhk T. (Hamburg), Christensen S. (Münster), Doerr H.W. (Frankfurt/M), Dupke S. (Berlin), Esser S. (Essen), Fleckenstein B. (Erlangen), Funk M. (Frankfurt/M), Gantke B. (Düsseldorf), Gellermann H.J. (Hamburg), Goebel F.-D. (München), Gölz J.(Berlin), Götzenich A. (Aachen), Grosch-Wörner I.(Berlin), Gürtler L. (Greifswald), Haberl A. (Frankfurt), Haerter G. (Ulm), Harrer T. (Erlangen), Hartmann M. (Heidelberg), Helm E.-B. (Frankfurt/M), Heise W. (Berlin), Hoffmann C. (Kiel), Hower M. (Bochum), Husstedt I. (Münster), Jablonowski H. (Salzgitter), Jägel-Guedes E. (München), Jäger H. (München), Karwat M. (München), Kerkau T. (Würzburg), Kern P. (Ulm), Klinker H. (Würzburg), Klüfer P. (Hamburg), Knechten H. (Aachen), Korn K. (Erlangen), Körner T. (Hannover), Kräusslich H.-G. (Heidelberg), Kramer A. (Greifswald), Kremer H. (Miami), Kreuter A. (Bochum), Kurowski M. (Berlin), Marcus U. (Berlin), Mauruschat S. (Wuppertal), Mauss S. (Düsseldorf), Mertens T. (Ulm), Mitrenga D. (Köln), Moll A. (Berlin), Mosthaf F. (Karlsruhe), Müller N. (Essen), Mutz A. (Osnabrück), Oette M. (Düsseldorf), Pfeil B. (Leipzig), Plettenberg A. (Hamburg), Rasokat H. (Köln), Reimann G. (Bochum), Rieger A. (Wien), Rieke A. (Koblenz), Rockstroh J. (Bonn), Rothe C. (Berlin), Ruf B. (Leipzig), Ruhnke M. (Berlin), Rump J.A. (Freiburg), Salzberger B. (Regensburg), Shah P. (Frankfurt), Schafberger A. (Berlin), Schedel I. (Hannover), Schewe K. (Hamburg), Schlottmann R. (Bochum), Schmalöer D. (Dortmund), Schmied B. (Wien), Schmidt B. (Erlangen), Schmidt R.E. (Hannover), Schneider T. (Berlin), Schöfer H. (Frankfurt), Schranz D. (Berlin), Sonnenberg-Schwan U. (München), Staszewski S. (Frankfurt), Stellbrink H.-J. (Hamburg), Stocker H. (Berlin), Stoehr A.(Hamburg), Stoll M (Hannover), Tschachler E. (Wien), Überla K. (Bochum), Ulmer A. (Stuttgart), van Lunzen J. (Hamburg), Vetter N. (Wien), Vielhaber B. (Berlin), Vocks-Hauck U. (Berlin), Walker U. (Freiburg), Weber S. (Bremen), Werner A. (Langen), Wolf E. (München), Wolf H. (Regensburg), Zangerle R. (Salzburg), Zeitz M. (Berlin), Zippel S. (München).
منابع مشابه
GERMAN - AUSTRIAN RECOMMENDATIONS FOR HIV 1 - THERAPY IN PREGNANCY AND IN HIV 1 - EXPOSED NEWBORN – UPDATE 2008 Common declaration
German-Austrian recommendations for HIV1-therapy in pregnancy Update 2008 Bernd Buchholz (University Medical Centre Mannheim, Pediatric Clinic), Matthias Beichert (Mannheim, Gynecology and Obstetrics Practice), Ulrich Marcus (Robert Koch Institute, Berlin), Thomas Grubert, Andrea Gingelmaier (Gynecology Clinic of the Ludwig Maximilians University of Munich), Dr. med. Annette Haberl (HIV-Departm...
متن کاملGerman-austrian recommendations for HIV1-therapy in pregnancy and in HIV1-exposed newborn - update 2008
In Germany during the last years about 200-250 HIV1-infected pregnant women delivered a baby each year, a number that is currently increasing. To determine the HIV-status early in pregnancy voluntary HIV-testing of all pregnant women is recommended in Germany and Austria as part of prenatal care. In those cases, where HIV1-infection was known during pregnancy, since 1995 the rate of vertical tr...
متن کاملCurrent antiretroviral drugs for human immunodeficiency virus infection: review article
Currently, there are about 37 million people worldwide living with human immunodeficiency virus (HIV) /AIDS, with an estimated two million new cases per year globally. According to estimates from the World Health Organization (WHO), only 75% of the population with HIV know their status. Initially, HIV infection was associated with significantly increased rates of mortality and morbidity. Howeve...
متن کاملThe treatment of chronic graft-versus-host disease: consensus recommendations of experts from Germany, Austria, and Switzerland.
BACKGROUND Chronic graft-versus-host disease (cGVHD) is the commonest complication of allogeneic bone marrow and blood stem-cell transplantation, occurring in 50% of all cases and causing late mortality in as many as 25%. There are now about 10 000 patients with cGVHD in Germany, and their number is growing by about 500 each year. cGVHD is a chronic multisystem disease due to impaired tolerance...
متن کاملMetabolic Abnormalities in HIV-Positive Patients Receiving Highly Active Antiretroviral Therapy
Background and Objective: Dyslipidemia has become a common problem in human immunodeficiency virus (HIV) disease, especially in patients on combination antiretroviral therapy. In this study we aimed to determine the prevalence of dyslipidemia and metabolic abnormalities in 2 groups of HIV infected patients receiving highly activ...
متن کامل